Literature DB >> 20176892

Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography-tandem mass spectrometry.

Fedja Farowski1, Oliver A Cornely, Jörg J Vehreschild, Pia Hartmann, Tim Bauer, Angela Steinbach, Maria J G T Rüping, Carsten Müller.   

Abstract

A rapid turnaround is a prerequisite of therapeutic drug monitoring (TDM). For antifungals, this need is still unmet, since hardly any method has been established to simultaneously quantitate concentrations of different antifungal classes. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed allowing quantitation of anidulafungin (ANF), caspofungin (CSF), isavuconazole (ISC), micafungin (MCF), posaconazole (PSC), and voriconazole (VRC). Quantitation was successful with diluted plasma samples, peripheral blood mononuclear cells (PBMC), polymorphonuclear leukocytes (PMN), and erythrocytes (RBC). A triple quadrupole mass spectrometer in selected reaction monitoring mode was used with positive electrospray ionization. Cells and calibration standards were extracted with acetonitrile containing internal standard. Internal standards were a CSF derivate for echinocandins and itraconazole for triazoles. Chromatographic separation of the supernatant was achieved by a gradient method facilitating a BetaBasic C4 column. Analytes were quantified in a single 8-min run. Calibration curves were linear and fitted using least squares with a weighting factor of the reciprocal concentration. Limits of detection (ng/ml) were ANF, 8.3; CSF, 31.5; ISC, 1.5; MCF, 97.7; PSC, 3.3; and VRC, 1.4. The lower limits of quantitation (ng/ml) were ANF, 64; CSF, 108; ISC, 4.5; MCF, 160; PSC, 10; and VRC, 4.2. Intraday precisions ranged from 6.3% to 8.8% for azoles and 8.8% to 15.4% for echinocandins. Intraday and interday accuracies (percent bias) of all analytes were within 13.8%. The method was established as standard practice for the quantitation of intracellular antifungal concentrations and optimizes TDM by applying a rapid single method for 6 antifungals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20176892      PMCID: PMC2863689          DOI: 10.1128/AAC.01276-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Determination of a cyclic hexapeptide, a novel antifungal agent, in human plasma by high-performance liquid chromatography with ion spray and turbo ion spray tandem mass spectrometric detection.

Authors:  C M Chavez-Eng; M Schwartz; M L Constanzer; B K Matuszewski
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-01-22

2.  Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.

Authors:  A Glasmacher; C Hahn; C Leutner; E Molitor; E Wardelmann; C Losem; T Sauerbruch; G Marklein; I G Schmidt-Wolf
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

3.  An advanced double column-switching technique (LC-LC) for liquid chromatography/electrospray ionisation tandem mass spectrometry for fully automated analysis of caspofungin.

Authors:  Hannes Egle; Rainer Trittler; Klaus Kümmerer
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

4.  Adverse reactions to voriconazole.

Authors:  Aileen E Boyd; Simon Modi; Susan J Howard; Caroline B Moore; Brian G Keevil; David W Denning
Journal:  Clin Infect Dis       Date:  2004-09-23       Impact factor: 9.079

5.  Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats.

Authors:  Toshiro Niwa; Yoshiko Yokota; Akira Tokunaga; Yasuhiro Yamato; Akira Kagayama; Tomoichi Fujiwara; Junko Hatakeyama; Masaharu Anezaki; Yuko Ohtsuka; Akira Takagi
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

6.  Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults.

Authors:  Rachel Courtney; Sudhakar Pai; Mark Laughlin; Josephine Lim; Vijay Batra
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

7.  Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.

Authors:  E Brummer; P R Bhagavathula; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 8.  Optimisation of itraconazole therapy using target drug concentrations.

Authors:  J M Poirier; G Cheymol
Journal:  Clin Pharmacokinet       Date:  1998-12       Impact factor: 6.447

9.  Uptake and intracellular activity of fluconazole in human polymorphonuclear leukocytes.

Authors:  A Pascual; I García; C Conejo; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.

Authors:  R Hyland; B C Jones; D A Smith
Journal:  Drug Metab Dispos       Date:  2003-05       Impact factor: 3.922

View more
  20 in total

1.  Intracellular concentrations of posaconazole in different compartments of peripheral blood.

Authors:  Fedja Farowski; Oliver A Cornely; Jörg J Vehreschild; Pia Hartmann; Tim Bauer; Angela Steinbach; Maria J G T Rüping; Carsten Müller
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

2.  Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.

Authors:  P Campoli; Q Al Abdallah; R Robitaille; N V Solis; J A Fielhaber; A S Kristof; M Laverdiere; S G Filler; D C Sheppard
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

3.  Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Authors:  Laurent Arthur Decosterd; Bertrand Rochat; Benoît Pesse; Thomas Mercier; Frédéric Tissot; Nicolas Widmer; Jacques Bille; Thierry Calandra; Boris Zanolari; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

4.  Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor.

Authors:  Chin Fen Neoh; Hui He; Jian Li; Robert O Fullinfaw; Lok Leung; Anant Misra; Rasik B Vajpayee; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

5.  Simultaneous quantitation of five triazole anti-fungal agents by paper spray-mass spectrometry.

Authors:  Christine L Skaggs; Greta J Ren; El Taher M Elgierari; Lillian R Sturmer; Run Z Shi; Nicholas E Manicke; Lindsey M Kirkpatrick
Journal:  Clin Chem Lab Med       Date:  2020-04-28       Impact factor: 3.694

6.  Phase II dose escalation study of caspofungin for invasive Aspergillosis.

Authors:  O A Cornely; J J Vehreschild; M J G T Vehreschild; G Würthwein; D Arenz; S Schwartz; C P Heussel; G Silling; M Mahne; J Franklin; U Harnischmacher; A Wilkens; F Farowski; M Karthaus; T Lehrnbecher; A J Ullmann; M Hallek; A H Groll
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

Review 7.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

8.  Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.

Authors:  Andreas H Groll; Georg Hempel; Silke Gastine; Thomas Lehrnbecher; Carsten Müller; Fedja Farowski; Peter Bader; Judith Ullmann-Moskovits; Oliver A Cornely
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

9.  Impact of Loading Dose of Caspofungin in Pharmacokinetic-Pharmacodynamic Target Attainment for Severe Candidiasis Infections in Patients in Intensive Care Units: the CASPOLOAD Study.

Authors:  Sébastien Bailly; Elodie Gautier-Veyret; Minh P Lê; Lila Bouadma; Olivier Andremont; Mathilde Neuville; Bruno Mourvillier; Romain Sonneville; Eric Magalhaes; Jordane Lebut; Aguila Radjou; Roland Smonig; Michel Wolff; Laurent Massias; Claire Dupuis; Jean-François Timsit
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.

Authors:  Gudrun Würthwein; Oliver A Cornely; Mirjam N Trame; Janne J Vehreschild; Maria J G T Vehreschild; Fedja Farowski; Carsten Müller; Joachim Boos; Georg Hempel; Michael Hallek; Andreas H Groll
Journal:  Antimicrob Agents Chemother       Date:  2013-01-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.